The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Audio Interview: FDA Progress Report and QbD Update
Emil Ciurczak speaks with Moheb Nasr, director of FDA's Office of Drug Quality, on developments at the Agency and Quality by Design (QbD).
Feb. 7, 2008
Click below to listen.
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Fujifilm Biotechnologies to leverage downstream purification system at UK site
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
Sponsored
Life Sciences Manufacturing Software Buyers Guide
Sponsored
AI Compliance in Life Sciences: 5 Essentials
Trending
JPM26: WuXi Biologics says it is poised for sustainable, high growth
Optimistic 2026 outlook emerges for biopharma industry as JPM26 wraps up
4 contract development and manufacturing organizations to watch in 2026
Sponsored Picks
Sponsored
AI-Powered QMS: The Future of Quality Management
Sponsored
Life Sciences Manufacturing Software Buyers Guide
Sponsored
AI Compliance in Life Sciences: 5 Essentials
Load More Content